Herbal Medicine

Hemp & CBD: Evidence, Evangelism & Extreme Exuberance

By Erik Goldman, Editor

If you are confused about the therapeutic value of hemp oil, cannabidiol (CBD), and other cannabis-related substances, and you’re scratching your head trying to figure out what’s legal and what’s not, that’s good: It means you’re paying attention.  Yes, there is some evidence, but there's also a lot of evangelism. Clinicians face the challenge of separating the scientific realities from the hype. 

Cannabis: State of the Science

By Erik Goldman, Editor

Is there any solid science to support the use of phytocannabinoids in clinical practice? The answer is yes….and no.

It depends on how you define “cannabis” and “cannabinoids;” whether you’re talking about inhaled (ie, smoked or vaped), ingested, or sublingual delivery; and of course, which diseases you’re considering.

Cannabis & Hemp: A Regulatory Update

By Erik Goldman, Editor

The year 2018 was a landmark in the history of hemp and cannabis in the US. It was the year the FDA approved the first natural cannabis-derived prescription drug, and Congress passed a Farm Bill that included provisions legalizing cultivation of, and interstate commerce in, low-THC hemp. But the laws and regulation around hemp and cannabis remain a confusing patchwork, and some states are taking regulatory actions that run counter to the new federal provisions.

Cannabis, Hemp, Marijuana: What's in a Name?

By Erik Goldman, Editor

Amid the current rage for all things cannabis, there is a lot of confusion about the terminology used to describe this plant and compounds extracted from it.

Part of that confusion arises from the Farm Bill of 2018, which changes some federal definitions. These changes have major implications for legal and regulatory policy.  Here’s a guide to common cannabis-related terms and their current definitions.

In "How to Change Your Mind," Michael Pollan Explores Resurgence of Psychedelic Medicine

By Ellen Kanner, Contributing Writer

After decades on the margins of both polite society and medical research, psychotropic compounds such as psilocybin, LSD, MDMA, and the like, are once again the focus of serious clinical investigation as potential therapies for a host of psychological and neurological conditions. In his newest book, How to Change Your Mind, popular author explores the resurgence of psychedelic medicine without bias, agenda, or pretense.

How the Endocannabinoid System Modulates Stress

By Carrie Decker, ND, Contributing Writer

In recent years, there has been a lot of interest--among practitioners and patients alike--in the impact of cannabis and cannabis-derived compounds for the modulation of pain, mood, inflammation, and immune system responsiveness. It should not be surprising that the endocannabinoid system (ECS) also plays a regulatory role in the body’s stress response mechanisms.

With TruQuality Program, Metagenics Ups the Ante on Transparency

By Erik Goldman

Many supplement and nutrition companies now make claims about their transparency and their products’ traceability. Few, however, publish complete data from their quality analysis testing for all the world to see. This year, Metagenics—one of the top three practitioner-channel brands—has taken that step, with its new TruQuality program.

Analytical Testing for Herbal Adulteration: An Interview With Elan Sudberg, Alkemist Labs

By Erik Goldman

Analytical testing laboratories are at the heart of all quality control endeavors in the dietary supplement industry. Few know more about it than Elan Sudberg, CEO, of Alkemist Labs, one of the nation's leading independent analytical laboratories serving the dietary supplement and natural products industries. In this in-depth interview, Sudberg shares his views on the state of quality control for herbal medicines and the direction for future improvements.